Phase II trial of mitolactol in patients with metastatic melanoma.
D000328:Adult; D000368:Aged; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008297:Male; D008545:Melanoma / Q000188:drug therapy*; D008875:Middle Aged; D008936:Mitolactol / Q000627:therapeutic use*; D009362:Neoplasm Metastasis
D008936:Mitolactol